Awarding Science Defense Again

David Nutt wins the second John Maddox Prize for promoting science despite opposition.

Written byAbby Olena, PhD
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

David NuttLAYTON THOMPSON, IMPERIAL COLLEGE LONDONDavid Nutt, a professor of neuropsychopharmacology at Imperial College London, has won the 2013 John Maddox Prize for Standing Up for Science. The award, a £2,000 cash prize jointly bestowed by Nature, the Kohn Foundation, and Sense About Science, is named for the Nature editor who “strove throughout his long working life for a better public understanding and appreciation of science,” Maddox’s friend Walter Gratzer, an emeritus professor of biophysical chemistry at King’s College London, said in this year’s prize announcement.

Nutt was famously fired as chairman of the UK Advisory Council on the Misuse of Drugs in 2009 when he commented publicly that the government’s drug laws were not evidence-based. His removal sparked unease in the scientific community and led to the formation of the Independent Scientific Committee on Drugs—a scientific source for information about drugs that Nutt now chairs—and to “the creation of the Principles for the Treatment of Independent Scientific Advice, which are now part of the Ministerial Code,” according to the prize announcement.

Nutt continues to use brain imaging to study and develop treatments for addiction, as well as to speak out against restrictions on research into the mechanisms and effects of illegal drugs. “Science is arguably the defining characteristic of humanity. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies